By Stephanie Pyle, Director of Communications and Design
After multiple delays, exceptions, and oh-so-many training sessions, on January 20, 2020, we reached the last remaining compliance milestone for the final revisions to the Federal Policy for the Protection of Human Subjects (“revised Common Rule”).
The Final Rule published in the Federal Register on January 19, 2017 (82 FR 7149), finalized the regulatory revisions, which seek to “modernize, simplify, and make more effective the current system of oversight” for clinical trials. Wondering what this all means for your research? Advarra’s got you covered with a variety of resources.